rs35179844

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_033641.4(COL4A6):​c.3373C>T​(p.Pro1125Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00662 in 1,210,551 control chromosomes in the GnomAD database, including 317 homozygotes. There are 2,183 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.035 ( 167 hom., 1068 hem., cov: 23)
Exomes 𝑓: 0.0038 ( 150 hom. 1115 hem. )

Consequence

COL4A6
NM_033641.4 missense

Scores

3
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.88

Publications

4 publications found
Variant links:
Genes affected
COL4A6 (HGNC:2208): (collagen type IV alpha 6 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene, alpha 5 type IV collagen, so that the gene pair shares a common promoter. Deletions in the alpha 5 gene that extend into the alpha 6 gene result in diffuse leiomyomatosis accompanying the X-linked Alport syndrome caused by the deletion in the alpha 5 gene. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]
COL4A6 Gene-Disease associations (from GenCC):
  • hearing loss, X-linked 6
    Inheritance: XL Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, PanelApp Australia
  • X-linked nonsyndromic hearing loss
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • premature ovarian failure 1
    Inheritance: XL Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0035195649).
BP6
Variant X-108170822-G-A is Benign according to our data. Variant chrX-108170822-G-A is described in ClinVar as Benign. ClinVar VariationId is 258273.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.116 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A6NM_033641.4 linkc.3373C>T p.Pro1125Ser missense_variant Exon 34 of 45 ENST00000334504.12 NP_378667.1 Q14031-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A6ENST00000334504.12 linkc.3373C>T p.Pro1125Ser missense_variant Exon 34 of 45 5 NM_033641.4 ENSP00000334733.7 Q14031-2

Frequencies

GnomAD3 genomes
AF:
0.0344
AC:
3883
AN:
112729
Hom.:
167
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.119
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00109
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000506
Gnomad OTH
AF:
0.0262
GnomAD2 exomes
AF:
0.0105
AC:
1919
AN:
183216
AF XY:
0.00700
show subpopulations
Gnomad AFR exome
AF:
0.127
Gnomad AMR exome
AF:
0.00740
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000294
Gnomad OTH exome
AF:
0.00420
GnomAD4 exome
AF:
0.00375
AC:
4122
AN:
1097769
Hom.:
150
Cov.:
31
AF XY:
0.00307
AC XY:
1115
AN XY:
363127
show subpopulations
African (AFR)
AF:
0.123
AC:
3247
AN:
26398
American (AMR)
AF:
0.00824
AC:
290
AN:
35203
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19384
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30202
South Asian (SAS)
AF:
0.000351
AC:
19
AN:
54131
European-Finnish (FIN)
AF:
0.0000493
AC:
2
AN:
40528
Middle Eastern (MID)
AF:
0.00556
AC:
23
AN:
4135
European-Non Finnish (NFE)
AF:
0.000177
AC:
149
AN:
841704
Other (OTH)
AF:
0.00851
AC:
392
AN:
46084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
156
311
467
622
778
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0345
AC:
3896
AN:
112782
Hom.:
167
Cov.:
23
AF XY:
0.0306
AC XY:
1068
AN XY:
34948
show subpopulations
African (AFR)
AF:
0.119
AC:
3685
AN:
31014
American (AMR)
AF:
0.0131
AC:
141
AN:
10742
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2657
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3567
South Asian (SAS)
AF:
0.000727
AC:
2
AN:
2751
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6271
Middle Eastern (MID)
AF:
0.00457
AC:
1
AN:
219
European-Non Finnish (NFE)
AF:
0.000506
AC:
27
AN:
53326
Other (OTH)
AF:
0.0259
AC:
40
AN:
1545
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
128
257
385
514
642
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0135
Hom.:
885
Bravo
AF:
0.0400
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.121
AC:
463
ESP6500EA
AF:
0.000297
AC:
2
ExAC
AF:
0.0113
AC:
1377
EpiCase
AF:
0.000600
EpiControl
AF:
0.000296

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 23, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 08, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Hearing loss, X-linked 6 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
14
DANN
Benign
0.62
DEOGEN2
Uncertain
0.43
.;T;.;.;T;T
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.79
T;T;D;D;T;T
MetaRNN
Benign
0.0035
T;T;T;T;T;T
MetaSVM
Benign
-0.51
T
MutationAssessor
Benign
1.5
.;L;.;.;.;.
PhyloP100
1.9
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-1.5
N;N;.;N;.;N
REVEL
Uncertain
0.29
Sift
Benign
0.42
T;T;.;T;.;T
Sift4G
Benign
0.10
T;T;D;D;T;T
Polyphen
0.12
B;B;.;B;.;B
Vest4
0.099
MPC
0.50
ClinPred
0.0078
T
GERP RS
2.3
Varity_R
0.044
gMVP
0.57
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35179844; hg19: chrX-107414052; API